Randomized Comparison of Initiating the Fixed-Ratio Combination of iGlarLixi or Biosimilar Insulin Glargine Together With Gliclazide in Participants of South Asian Origin With Type 2 Diabetes: VARIATION 2 SA Trial

Harpreet S Bajaj,Lisa Chu,Nandini Bansal,Ruth E Brown,Gagandeep Dhillon,Rishabh Gupta,Jatminderpal S Bhela, Jagjit K Padda,Hasnain Khandwala,Karri Venn,Ronnie Aronson

Canadian journal of diabetes（2022）

引用 2|浏览5

暂无评分

摘要

Initiation of iGlarLixi resulted in similar TIR, A1C, FPG, weight and hypoglycemia compared with the more affordable option of starting iGlar + gliclazide in adults of South Asian origin with T2D.

查看译文

关键词

insulin,South Asian,time in range,type 2 diabetes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要